CD40LG and rheumatoid arthritis: Further, IgG anti-THRB328−345 (OR 5.761), IgG anti-THRB328−345 HNE (OR 9.542), and IgM anti-THRB328−345 HNE (OR 5.043) exhibited risks for RA development (Table 4).